Stockreport

X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]

X4 Pharmaceuticals, Inc.  (XFOR) 
Last x4 pharmaceuticals, inc. earnings: 3/12 07:30 am Check Earnings Report
PDF Pivotal Phase 3 trial of mavorixafor in CN on track to fully enroll in mid-2025 U.S. launch of XOLREMDI® (mavorixafor) in WHIM underway; submission of Marketing Autho [Read more]